AggreGuide 325 mg. Aspirin Study for Aspirin Induced Platelet Dysfunction

Completed

• Conditions: Platelet Dysfunction Due to Aspirin Ingestion

• Registration Number: NCT01915407
• Lead Sponsor: Aggredyne, Inc.

Brief Summary

To test the AggreGuide A-100 AA Assay's effectiveness for detecting aspirin induced platelet dysfunction.

Detailed Description

Not available

Study Timeline

• Study Start: 2013-04
• Primary Completion: 2013-07
• Study Completion: 2013-07
• Study First Submitted: 2013-07-30
• Status Verified: 2013-08
• Study First Submitted QC: 2013-08-01
• Last Update Submitted: 2013-08-01
• Study First Posted: 2013-08-02
• Last Update Posted: 2013-08-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

• over 18

Exclusion Criteria

• on aspirin in prior week
• medical history of platelet disorders
• contraindications to aspirin

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Platelet Activity Index (PAI) before and after ingestion of aspirin	2 - 30 hours post aspirin ingestion	PAI is the proprietary reporting unit of the Aggreguide. It is related to the amount of platelet aggregation in the sample of whole blood.

Trial Locations

Locations (1)

Aggredyne, Inc.; 🇺🇸 Houston, Texas, United States